Mark Mennemeier
Concepts (212)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Transcranial Magnetic Stimulation | 11 | 2018 | 81 | 2.940 |
Why?
| Tinnitus | 10 | 2017 | 62 | 2.820 |
Why?
| Attention | 20 | 2020 | 185 | 2.280 |
Why?
| Perceptual Disorders | 8 | 2011 | 18 | 1.520 |
Why?
| Psychomotor Performance | 12 | 2017 | 156 | 1.480 |
Why?
| Stroke | 6 | 2014 | 526 | 0.930 |
Why?
| Neuropsychological Tests | 13 | 2012 | 363 | 0.900 |
Why?
| Functional Laterality | 9 | 2012 | 99 | 0.890 |
Why?
| Perception | 2 | 2017 | 142 | 0.820 |
Why?
| Temporal Lobe | 4 | 2017 | 75 | 0.710 |
Why?
| Reaction Time | 10 | 2017 | 227 | 0.660 |
Why?
| Brain Injuries | 3 | 2014 | 184 | 0.540 |
Why?
| Space Perception | 6 | 2006 | 19 | 0.530 |
Why?
| Peroneal Nerve | 1 | 2014 | 4 | 0.510 |
Why?
| Transcutaneous Electric Nerve Stimulation | 1 | 2014 | 8 | 0.510 |
Why?
| Cold Temperature | 2 | 2011 | 53 | 0.490 |
Why?
| Patient Admission | 1 | 2014 | 78 | 0.480 |
Why?
| Aged | 24 | 2018 | 10060 | 0.480 |
Why?
| Gait Disorders, Neurologic | 1 | 2014 | 36 | 0.470 |
Why?
| Regional Blood Flow | 3 | 2011 | 121 | 0.470 |
Why?
| Brain | 4 | 2012 | 1392 | 0.450 |
Why?
| Middle Aged | 26 | 2018 | 13082 | 0.450 |
Why?
| Size Perception | 3 | 2005 | 4 | 0.430 |
Why?
| Positron-Emission Tomography | 4 | 2011 | 323 | 0.430 |
Why?
| Cross-Over Studies | 6 | 2018 | 250 | 0.430 |
Why?
| Hypnosis | 1 | 2012 | 7 | 0.430 |
Why?
| Male | 34 | 2018 | 27347 | 0.430 |
Why?
| Visual Fields | 5 | 2006 | 56 | 0.430 |
Why?
| Adult | 25 | 2020 | 14207 | 0.410 |
Why?
| Dominance, Cerebral | 7 | 2008 | 28 | 0.400 |
Why?
| Pilot Projects | 6 | 2018 | 807 | 0.390 |
Why?
| Evoked Potentials, Somatosensory | 1 | 2011 | 12 | 0.390 |
Why?
| Female | 33 | 2018 | 28471 | 0.380 |
Why?
| Orientation | 5 | 2005 | 17 | 0.370 |
Why?
| Humans | 45 | 2020 | 54391 | 0.360 |
Why?
| Visual Perception | 6 | 2011 | 42 | 0.360 |
Why?
| Cerebral Infarction | 4 | 2006 | 32 | 0.350 |
Why?
| Cognition Disorders | 1 | 2011 | 240 | 0.340 |
Why?
| Prefrontal Cortex | 5 | 2017 | 89 | 0.340 |
Why?
| Pattern Recognition, Visual | 5 | 2004 | 22 | 0.330 |
Why?
| Blood Glucose | 1 | 2011 | 489 | 0.310 |
Why?
| Cognition | 5 | 2018 | 350 | 0.300 |
Why?
| Hospitalization | 1 | 2011 | 704 | 0.290 |
Why?
| Parietal Lobe | 3 | 2017 | 30 | 0.280 |
Why?
| Thinking | 2 | 2004 | 21 | 0.280 |
Why?
| Self-Assessment | 1 | 2006 | 50 | 0.280 |
Why?
| Muscle Contraction | 1 | 2006 | 111 | 0.270 |
Why?
| Double-Blind Method | 5 | 2020 | 743 | 0.260 |
Why?
| Automobile Driving | 2 | 2002 | 30 | 0.260 |
Why?
| Treatment Outcome | 7 | 2018 | 5612 | 0.250 |
Why?
| Sensory Thresholds | 4 | 2015 | 20 | 0.240 |
Why?
| Psychophysics | 2 | 2003 | 5 | 0.240 |
Why?
| Young Adult | 7 | 2017 | 4318 | 0.230 |
Why?
| Habituation, Psychophysiologic | 2 | 2011 | 31 | 0.220 |
Why?
| Brain Damage, Chronic | 3 | 1997 | 14 | 0.210 |
Why?
| Hemiplegia | 3 | 2012 | 12 | 0.200 |
Why?
| Vision Disorders | 1 | 2002 | 74 | 0.200 |
Why?
| Arousal | 4 | 2011 | 105 | 0.200 |
Why?
| Caffeine | 2 | 2020 | 77 | 0.190 |
Why?
| Thalamic Nuclei | 2 | 1997 | 10 | 0.190 |
Why?
| Disorders of Excessive Somnolence | 1 | 2020 | 7 | 0.190 |
Why?
| Aged, 80 and over | 5 | 2011 | 3431 | 0.180 |
Why?
| Central Nervous System Stimulants | 2 | 2020 | 255 | 0.180 |
Why?
| Adolescent | 6 | 2017 | 6900 | 0.170 |
Why?
| Pain Measurement | 2 | 2011 | 248 | 0.170 |
Why?
| Cerebral Cortex | 4 | 2006 | 234 | 0.160 |
Why?
| Psychometrics | 2 | 2012 | 239 | 0.160 |
Why?
| Basal Ganglia | 2 | 1997 | 26 | 0.160 |
Why?
| Alpinia | 1 | 2017 | 2 | 0.160 |
Why?
| Deglutition | 2 | 2015 | 37 | 0.160 |
Why?
| Verbal Behavior | 2 | 1997 | 35 | 0.160 |
Why?
| Plant Preparations | 1 | 2017 | 38 | 0.150 |
Why?
| Apathy | 1 | 2018 | 47 | 0.150 |
Why?
| Predictive Value of Tests | 2 | 2017 | 1045 | 0.130 |
Why?
| Oropharynx | 1 | 2015 | 14 | 0.130 |
Why?
| Foot | 2 | 2011 | 50 | 0.130 |
Why?
| Mouth | 1 | 2015 | 35 | 0.130 |
Why?
| Proprioception | 1 | 1994 | 9 | 0.130 |
Why?
| Frontal Lobe | 2 | 1994 | 56 | 0.130 |
Why?
| Reference Values | 2 | 2006 | 354 | 0.120 |
Why?
| Magnetic Resonance Imaging | 3 | 2017 | 1616 | 0.120 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2017 | 594 | 0.120 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2014 | 92 | 0.120 |
Why?
| Brain Diseases | 1 | 1994 | 88 | 0.120 |
Why?
| Locomotion | 1 | 2014 | 83 | 0.120 |
Why?
| Biofeedback, Psychology | 1 | 2013 | 16 | 0.120 |
Why?
| Fiber Optic Technology | 1 | 2013 | 17 | 0.120 |
Why?
| Electromyography | 1 | 2014 | 150 | 0.120 |
Why?
| Electric Stimulation | 1 | 2013 | 94 | 0.120 |
Why?
| Severity of Illness Index | 4 | 2006 | 1082 | 0.110 |
Why?
| Research Design | 2 | 2013 | 375 | 0.110 |
Why?
| Cerebrovascular Disorders | 4 | 1998 | 53 | 0.110 |
Why?
| Visual Acuity | 2 | 2006 | 143 | 0.110 |
Why?
| Anesthetics | 1 | 2013 | 36 | 0.110 |
Why?
| Suggestion | 1 | 2012 | 6 | 0.110 |
Why?
| Endoscopy | 1 | 2013 | 131 | 0.110 |
Why?
| Deglutition Disorders | 1 | 2013 | 71 | 0.110 |
Why?
| Spatial Behavior | 2 | 2004 | 13 | 0.100 |
Why?
| Fluorodeoxyglucose F18 | 2 | 2011 | 212 | 0.100 |
Why?
| Age Factors | 2 | 2015 | 1199 | 0.100 |
Why?
| Language | 1 | 2012 | 137 | 0.100 |
Why?
| Feasibility Studies | 2 | 2011 | 398 | 0.100 |
Why?
| Radiography | 1 | 2012 | 526 | 0.100 |
Why?
| Reproducibility of Results | 2 | 2006 | 1301 | 0.090 |
Why?
| Home Care Services | 1 | 2011 | 79 | 0.090 |
Why?
| Decision Making | 1 | 2013 | 286 | 0.090 |
Why?
| Time Factors | 3 | 2013 | 3210 | 0.090 |
Why?
| Algorithms | 2 | 2004 | 697 | 0.090 |
Why?
| Dementia | 1 | 2011 | 150 | 0.090 |
Why?
| Clinical Trials as Topic | 1 | 2012 | 491 | 0.090 |
Why?
| Multivariate Analysis | 1 | 2011 | 643 | 0.090 |
Why?
| Aging | 1 | 2015 | 784 | 0.090 |
Why?
| Analysis of Variance | 1 | 2011 | 634 | 0.090 |
Why?
| Chronic Disease | 1 | 2012 | 614 | 0.090 |
Why?
| Equipment Safety | 1 | 2008 | 16 | 0.080 |
Why?
| Electroencephalography | 1 | 2011 | 357 | 0.080 |
Why?
| Smoking | 1 | 2013 | 552 | 0.080 |
Why?
| Retreatment | 1 | 2008 | 57 | 0.080 |
Why?
| Muscle, Skeletal | 1 | 2014 | 847 | 0.080 |
Why?
| rRNA Operon | 1 | 1997 | 2 | 0.080 |
Why?
| Secondary Prevention | 1 | 2008 | 89 | 0.080 |
Why?
| Mycobacterium | 1 | 1997 | 20 | 0.080 |
Why?
| Ribosomes | 1 | 1997 | 33 | 0.080 |
Why?
| Cues | 2 | 2005 | 55 | 0.070 |
Why?
| Sensation | 1 | 2006 | 15 | 0.070 |
Why?
| Arm | 1 | 2006 | 52 | 0.070 |
Why?
| Restraint, Physical | 1 | 2006 | 21 | 0.070 |
Why?
| Energy Metabolism | 1 | 2008 | 311 | 0.070 |
Why?
| Leg | 1 | 2006 | 130 | 0.070 |
Why?
| Prospective Studies | 2 | 2015 | 2606 | 0.060 |
Why?
| Promoter Regions, Genetic | 1 | 1997 | 520 | 0.060 |
Why?
| Memory | 1 | 2005 | 124 | 0.060 |
Why?
| Quality of Life | 1 | 2011 | 924 | 0.060 |
Why?
| Exercise Therapy | 1 | 2006 | 123 | 0.060 |
Why?
| Follow-Up Studies | 4 | 2017 | 2390 | 0.060 |
Why?
| Photic Stimulation | 1 | 2004 | 65 | 0.060 |
Why?
| Behavior Therapy | 1 | 2006 | 203 | 0.060 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 231 | 0.060 |
Why?
| Single-Blind Method | 2 | 2013 | 120 | 0.060 |
Why?
| Contrast Sensitivity | 1 | 2002 | 5 | 0.050 |
Why?
| Fixation, Ocular | 1 | 2002 | 20 | 0.050 |
Why?
| Activities of Daily Living | 1 | 2002 | 204 | 0.050 |
Why?
| Hemianopsia | 1 | 2000 | 6 | 0.050 |
Why?
| Tomography, Emission-Computed, Single-Photon | 2 | 1997 | 57 | 0.050 |
Why?
| Brain Mapping | 2 | 1997 | 250 | 0.040 |
Why?
| Thalamic Diseases | 1 | 1997 | 1 | 0.040 |
Why?
| Word Association Tests | 1 | 1997 | 2 | 0.040 |
Why?
| Speech Articulation Tests | 1 | 1997 | 3 | 0.040 |
Why?
| Executive Function | 1 | 2018 | 80 | 0.040 |
Why?
| Discrimination Learning | 1 | 1997 | 49 | 0.040 |
Why?
| Fingers | 1 | 1997 | 42 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2002 | 1696 | 0.040 |
Why?
| Thalamus | 2 | 2006 | 33 | 0.040 |
Why?
| Sleep | 1 | 2017 | 188 | 0.030 |
Why?
| Tomography, X-Ray Computed | 4 | 2007 | 1222 | 0.030 |
Why?
| Anxiety | 1 | 2017 | 279 | 0.030 |
Why?
| Body Mass Index | 1 | 2017 | 712 | 0.030 |
Why?
| Posture | 1 | 1994 | 79 | 0.030 |
Why?
| Control Groups | 1 | 2013 | 10 | 0.030 |
Why?
| Administration, Topical | 1 | 2013 | 71 | 0.030 |
Why?
| Gambling | 1 | 2013 | 19 | 0.030 |
Why?
| Nose | 1 | 2013 | 42 | 0.030 |
Why?
| Alzheimer Disease | 1 | 2018 | 369 | 0.030 |
Why?
| Aphasia, Wernicke | 1 | 1992 | 4 | 0.030 |
Why?
| Data Interpretation, Statistical | 1 | 2013 | 177 | 0.030 |
Why?
| Impulsive Behavior | 1 | 2013 | 82 | 0.030 |
Why?
| Reward | 1 | 2013 | 123 | 0.030 |
Why?
| Choice Behavior | 1 | 2013 | 95 | 0.030 |
Why?
| Evidence-Based Medicine | 1 | 2012 | 276 | 0.020 |
Why?
| Mycobacterium phlei | 1 | 1997 | 1 | 0.020 |
Why?
| Mycobacterium chelonae | 1 | 1997 | 6 | 0.020 |
Why?
| Mycobacterium fortuitum | 1 | 1997 | 6 | 0.020 |
Why?
| RNA, Ribosomal | 1 | 1997 | 18 | 0.020 |
Why?
| Awareness | 2 | 2002 | 32 | 0.020 |
Why?
| Genes, Bacterial | 1 | 1997 | 67 | 0.020 |
Why?
| RNA, Bacterial | 1 | 1997 | 58 | 0.020 |
Why?
| Cloning, Molecular | 1 | 1997 | 198 | 0.020 |
Why?
| Sequence Alignment | 1 | 1997 | 146 | 0.020 |
Why?
| RNA, Ribosomal, 16S | 1 | 1997 | 116 | 0.020 |
Why?
| Chromosome Mapping | 1 | 1997 | 175 | 0.020 |
Why?
| DNA, Bacterial | 1 | 1997 | 172 | 0.020 |
Why?
| Plasmids | 1 | 1997 | 180 | 0.020 |
Why?
| Virulence | 1 | 1997 | 196 | 0.020 |
Why?
| Auditory Cortex | 1 | 2006 | 21 | 0.020 |
Why?
| Molecular Structure | 1 | 1997 | 319 | 0.020 |
Why?
| Therapy, Computer-Assisted | 1 | 2006 | 34 | 0.020 |
Why?
| Genome, Bacterial | 1 | 1997 | 141 | 0.020 |
Why?
| Sequence Analysis, DNA | 1 | 1997 | 274 | 0.020 |
Why?
| Base Sequence | 1 | 1997 | 719 | 0.020 |
Why?
| Physical Stimulation | 1 | 2006 | 36 | 0.020 |
Why?
| Audiometry, Evoked Response | 1 | 2006 | 8 | 0.020 |
Why?
| Paresis | 1 | 2006 | 5 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 1997 | 531 | 0.020 |
Why?
| Transcription, Genetic | 1 | 1997 | 418 | 0.020 |
Why?
| Psychological Tests | 1 | 2006 | 53 | 0.020 |
Why?
| Task Performance and Analysis | 1 | 2006 | 61 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 1997 | 980 | 0.020 |
Why?
| Brain Stem | 1 | 2006 | 46 | 0.020 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 1997 | 246 | 0.020 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2006 | 204 | 0.020 |
Why?
| Evoked Potentials, Auditory | 1 | 2006 | 97 | 0.020 |
Why?
| Arkansas | 1 | 2011 | 2100 | 0.020 |
Why?
| Benzhydryl Compounds | 1 | 2006 | 75 | 0.020 |
Why?
| Radiopharmaceuticals | 1 | 2006 | 242 | 0.020 |
Why?
| Ambulatory Care Facilities | 1 | 2006 | 138 | 0.020 |
Why?
| Neuroprotective Agents | 1 | 2006 | 125 | 0.020 |
Why?
| Case-Control Studies | 1 | 2006 | 1229 | 0.010 |
Why?
| Random Allocation | 1 | 2002 | 312 | 0.010 |
Why?
| Accidents, Traffic | 1 | 2002 | 117 | 0.010 |
Why?
| Confusion | 1 | 1997 | 20 | 0.010 |
Why?
| Distance Perception | 1 | 1994 | 4 | 0.010 |
Why?
| Problem Solving | 1 | 1994 | 46 | 0.010 |
Why?
|
|
Mennemeier's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|